Aspirin-Exacerbated Respiratory Disease (AERD)
Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome where aspirin and other COX-1 inhibiting NSAIDs—including ibuprofen—trigger acute respiratory reactions in patients with chronic rhinosinusitis with nasal polyps and asthma. 1
What is AERD?
AERD is characterized by the clinical triad of:
- Chronic rhinosinusitis with nasal polyps
- Asthma (typically eosinophilic)
- Respiratory reactions to aspirin and NSAIDs that inhibit COX-1
Patients develop respiratory symptoms within 30 to 180 minutes after ingesting NSAIDs such as aspirin or ibuprofen 2. These reactions manifest as bronchospasm, nasal congestion, rhinorrhea, and potentially severe asthma exacerbations that can be fatal 3.
Is Ibuprofen Related? YES.
Ibuprofen absolutely triggers the same respiratory reactions as aspirin in patients with AERD 1, 3. This is critical to understand:
- All COX-1 inhibiting NSAIDs cross-react in AERD patients 1
- Ibuprofen is a strong COX-1 inhibitor and will cause respiratory reactions in AERD patients
- The FDA label for ibuprofen explicitly states: "ibuprofen tablets should not be administered to patients with this form of aspirin sensitivity" 3
- When patients have a history of multiple reactions to structurally dissimilar NSAIDs (e.g., both ibuprofen and aspirin), the rate of positive aspirin challenge increases to confirm AERD 1
The Mechanism
The reaction is not IgE-mediated or drug-specific—it occurs through COX-1 inhibition, causing dysregulation of arachidonic acid metabolism with increased cysteinyl leukotrienes and decreased prostaglandin E2 1, 2. This is why all COX-1 inhibitors cross-react.
Clinical Recognition
You should suspect AERD when a patient has:
- Nasal polyposis with asthma
- Acute onset respiratory symptoms (bronchospasm, nasal congestion, rhinorrhea) within 30-180 minutes after taking aspirin or any NSAID including ibuprofen
- History of multiple reactions to different NSAIDs 1
In patients with ≥2 respiratory reactions to different NSAIDs or a respiratory reaction requiring hospitalization, further diagnostic testing with aspirin challenge is unnecessary—the diagnosis is clinical 1.
Safe Alternatives
Selective COX-2 inhibitors (like celecoxib) are safe alternatives 1:
- Reactions to selective COX-2 inhibitors are extremely rare in AERD patients
- They can typically be taken safely because they don't inhibit COX-1 at therapeutic doses
- The 2022 practice parameter recommends selective COX-2 inhibitors as alternative analgesics in any NSAID hypersensitivity phenotype 1
Acetaminophen is generally tolerated at lower doses, though it is a weak COX-1 inhibitor and may cause reactions in highly sensitive individuals at higher doses (650-1000 mg) 1.
Management Approach
For patients with confirmed or suspected AERD:
Avoid all COX-1 inhibiting NSAIDs including ibuprofen, naproxen, ketorolac, and aspirin 1
Use selective COX-2 inhibitors (celecoxib) when NSAID therapy is needed 1
Aggressive medical management of underlying asthma and chronic rhinosinusitis 1
Consider aspirin desensitization if aspirin is medically necessary or for therapeutic benefit—this improves both upper and lower respiratory disease and creates tolerance to all COX-1 inhibiting NSAIDs including ibuprofen 1
Important Caveat About Desensitization
Once desensitized to aspirin, universal tolerance to all COX-1 inhibiting NSAIDs (including ibuprofen) is achieved 1. However, continuous daily aspirin (at least 325 mg daily) is required to maintain tolerance—gaps >48 hours may lead to loss of tolerance 1.
Ibuprofen can be used as a "bridge" during surgical procedures to maintain tolerance while minimizing bleeding risk from aspirin 1, but this requires the patient to already be desensitized.
Bottom Line
Ibuprofen is absolutely contraindicated in patients with AERD or suspected aspirin-sensitive asthma 3. It will trigger the same respiratory reactions as aspirin because both inhibit COX-1. Use selective COX-2 inhibitors instead when NSAID therapy is needed.